- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03330717
Interventional Study on the Impact of the Hypnosis Used as Sedation or Relaxation in the Breast Oncologic Surgery (OncoHypnose)
Interventional Study on the Impact of the Hypnosis Used as Sedation or Relaxation (Virtual Reality) in the Breast Oncologic Surgery
The aims of the study are to compare the recovering period between a group of patients with conventional sedation, a group using hypnosis as sedation during the surgery and a third group using hypnosis as a relaxation method and preparation but enjoying a classic sedation for their surgery.
Comparaison of pain ( different types of pain), consumption of pain killers ,anxiety and fatigue on day0,1, 8 after surgery and every. 3 months during the first 2 years of follow up.
Comparisons are also performed in substudies defined by treatments modalités. Inflammatory parameters s ( CRP_ C reactive protein, NLR- ( neutrophils to lymphocyte ratio) are measured on Day 0, 1, 8 and also salivary Immunoglobulins and different endocannabinoids.
Study Overview
Status
Conditions
Detailed Description
Hypnosis has already demonstrated benefits among breast cancer patients undergoing oncologic surgery. Different side effects were measured during the post operative period and at each follow up visit by physicians in order to carefully compare side effects in the 3 armes of patients..
Our hypothesis was that hypnosis sedation generates less perioperative inflammatory reaction.
A substudy of 50 patients was also dedicated to the investigation ofsalivary immunoglobulins and dosage of differents endocannabinoids
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Brussels, Belgium, 1200
- Cliniques Universitaires Saint-Luc
-
-
Hainaut
-
Haine-Saint-Paul, Hainaut, Belgium, 7100
- Hôpital de Jolimont
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patient over 18 years old
- Signed informed consent form
- Patient has to be in possession of her administrative laws and affiliated to the social security insurance.
- The patient must have a diagnosis of resectable breast cancer (in situ or invasive breast cancer). . Surgical procedure must include evaluation of the axillary area (sentinel lymph node biopsy and or axillary dissection)
Exclusion Criteria:
- Patient under 18 years old
- No signed informed consent form
- Patients who haven't her social security insurance and prisoners are not eligible.
- No evaluation of the axillary area.
- Breast cancer in men
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: General anesthesia
Patients will undergo oncologic breast surgery on general anesthesia.
|
Patients will undergo oncologic breast surgery on general anesthesia.
|
Experimental: Hypnosis sedation
Patients will undergo oncologic breast surgery on hypnosis sedation.
|
Patients will undergo oncologic breast surgery on hypnosis sedation.
|
Experimental: General anesthesia with preoperative session of hypnosis
Patients interested in hypnosis but too anxious to have surgery while on hypnosis sedation will undergo surgery on general anesthesia but will have a preoperative session of hypnosis relaxation using technology of virtual reality
|
Patients will undergo surgery on general anesthesia but will have a preoperative session of hypnosis relaxation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of the days spent at the hospital post-surgery between the three groups
Time Frame: Day 0, 1, 8 and every 3 months for 2 years after surgery
|
The aim of the study is to compare the recovering period hospitalisation and the different side effects (pain, anxiety, fatigue and consumption of pain killers ) during the post opérative period ( day 0, 1, 8- and at each follow up visit) between a group of patients with conventional sedation, a group using hypnosis as sedation during the surgery and a third group using hypnosis as a relaxation method and preparation but enjoying a classic sedation for their surgery
|
Day 0, 1, 8 and every 3 months for 2 years after surgery
|
Comparaison of inflammatory parameters measured on day 0,1,8: CRP ( c reactive protein) and NLR ( neutrophils to lymphocyte ratio)
Time Frame: Day 0, 1, 8
|
Blood test performed
|
Day 0, 1, 8
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Substudy evaluation of salivary immunoglobulins and endocannabinoids among 50 patients (25 under general anesthesia and 25 under hypnosis sedation
Time Frame: Simples collected on Day 0, 1 and 8 for endocannabinoids and salivary simples collected on Day 0 and 8
|
Blood and salivary simples to observe if hypnosis modifies salivary parameters and endocannabinoids system
|
Simples collected on Day 0, 1 and 8 for endocannabinoids and salivary simples collected on Day 0 and 8
|
Collaborators and Investigators
Investigators
- Principal Investigator: Martine Berlière, MD, PhD, Cliniques Universitaires Saint-Luc
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2016/08JUL/311
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Breast Neoplasm
-
National Cancer Institute (NCI)RecruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Triple-Negative Breast CarcinomaUnited States
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...Not yet recruitingBreast Cancer | Neoplasm, Breast | Malignant Neoplasm of Breast | Breast Tumor | Mammary Cancer | Mammary Neoplasms, Human | Tumor, Breast | Mammary NeoplasmUnited States
-
Jonsson Comprehensive Cancer CenterU.S. Army Medical Research and Development Command; U.S. Army Medical Research...CompletedBreast Carcinoma | Malignant Breast Neoplasm | Benign Breast NeoplasmUnited States
-
National Cancer Institute (NCI)RecruitingAdvanced Malignant Solid Neoplasm | Refractory Malignant Solid Neoplasm | Unresectable Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | HER2-Positive Breast CarcinomaUnited States
-
Indiana UniversityIndiana University HealthCompletedBreast Cancer | Breast Neoplasms | Anxiety | Breast Carcinoma | Fear | Cancer of Breast | Malignant Tumor of Breast | Malignant Neoplasm of Breast | Mammary Cancer | Human Mammary Carcinoma | Mammary Neoplasm, Human | Mammary Carcinoma | Neoplasm Remission, Spontaneous | Spontaneous Neoplasm Regression | Regression,... and other conditionsUnited States
-
National Cancer Institute, ThailandCompleted
-
Umbria Bioengineering TechnologiesToscana Life Sciences Sviluppo s.r.l.; London South Bank University; ELAROS 24... and other collaboratorsRecruitingWomen's Health: Neoplasm of BreastItaly, Spain, Poland, Portugal, Switzerland
-
Istanbul Aydın UniversityActive, not recruiting
-
University of OviedoCompletedWomen's Health: Neoplasm of BreastSpain
-
National Cancer Institute, ThailandCompleted
Clinical Trials on General anesthesia
-
Peking University First HospitalPeking University; Peking University People's Hospital; Peking University Third... and other collaboratorsCompletedElderly | Long-term Outcome | Malignant Tumor | Epidural Anesthesia | Surgical ResectionChina
-
Boston Children's HospitalFood and Drug Administration (FDA); Royal Children's Hospital; Murdoch Childrens... and other collaboratorsCompletedInguinal HerniaUnited States, Canada, Australia, Italy, United Kingdom, Netherlands, New Zealand
-
Ohio State University Comprehensive Cancer CenterRecruitingPancreatic AdenocarcinomaUnited States
-
University of Lausanne HospitalsWithdrawn
-
Peking University First HospitalPeking University People's Hospital; Peking University Third Hospital; Beijing... and other collaboratorsCompletedLong-term Outcome | Elderly Patients | Epidural Anesthesia | Solid Organ Cancer | Surgical ResectionChina
-
University of PennsylvaniaPatient-Centered Outcomes Research InstituteActive, not recruitingHip FracturesUnited States, Canada
-
Second Affiliated Hospital of Wenzhou Medical UniversityRecruitingDepression, AnxietyChina
-
Peking University First HospitalCompletedNeoplasm Metastasis | Lung Cancer | Thoracic Surgery | Anesthesia, Epidural | Neoplasm Recurrence, LocalChina
-
Daniel Gioielli de CastilhoCompletedSpinal Anesthesia | Postoperative Care | Fentanyl | Myocardial RevascularizationBrazil
-
Queen Fabiola Children's University HospitalRecruiting